Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
Journal
-
- The Lancet
-
The Lancet 397 (10292), 2361-2371, 2021-06
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1360017287056705536
-
- ISSN
- 01406736
-
- Data Source
-
- Crossref